Meisner Lara's Form 4 filing
Bicara Therapeutics Inc. (BCAX) · filed Mar 18, 2025
- Accession no.
- 0000950170-25-041546
- Filed
- Mar 18, 2025
- Trade date
- Mar 14, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.02M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Meisner LaraCIK 0001883986 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Common Stock | MOption exerciseAcquired | +79,146 | $5.45 | +$431,345.7 | 79,145 | Direct | |
| Mar 14, 2025 | Common Stock | SSaleDisposed | −48,526 | $12.69 | −$615,794.94 | 30,620 | Direct | |
| Mar 14, 2025 | Common Stock | SSaleDisposed | −30,620 | $13.24 | −$405,408.8 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | Common Stock | MOption exerciseDisposed | −48,720 | $0.00 | $0 | 107,187 | Direct | |
| Mar 14, 2025 | Common Stock | MOption exerciseDisposed | −30,246 | $0.00 | $0 | 67,119 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.